Hogan Lovells advises Celgene in its latest strategic collaboration with Skyhawk Therapeutics
Press releases
| 15
November
2019
New York, 15 November 2019 – Global law firm Hogan Lovells advised Celgene Corporation in its second global strategic collaboration with Skyhawk Therapeautics. The deal closed on 12 November.
For more information, please see Skyhawk’s press release.
The deal team on behalf of Celgene was led by Hogan Lovells partner Adam Golden, along with senior associate Erin Howell and associate Joel Dankwa.